Import Alerts

Dabur Facility Placed Under Import Alert

The USFDA has placed Dabur’s Dadra and Nager Haveli facility under Import Alert 66-40 in

Facility Registration Violations, Refusa

Indian API manufacturer Jagsonpal Pharmaceuticals was issued a Warning Letter by the US FDA in

Chine API Manufacturer Chengdu KeCheng I

The USFDA issued a Warning Letter to the Chinese API manufacturer Chengdu KeCheng Fine Chemicals